Follow-The-Filings

Security · featured owners

CGEM Cullinan Oncology Inc.

Health Care COM Equity among managers we track

CGEM (Cullinan Oncology Inc.) 13F ownership among featured managers we track. Figures are as-filed 13F, not free float.

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

SEC filings

Recent issuer filings from EDGAR · 13 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 7.01,8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 12 rows shown

Filed Form Detail Links
4 Period Sep 8, 2026 Filing Doc
4 Period Aug 13, 2026 Filing Doc
4 Period Jul 6, 2026 Filing Doc
4 Period Jun 30, 2026 · 2 forms Filing Doc
4 Period Jun 16, 2026 · 6 forms Filing Doc
4 Period May 5, 2026 Filing Doc
4 Period Mar 5, 2026 Filing Doc
4 Period Feb 25, 2026 Filing Doc
4 Period Feb 24, 2026 · 3 forms Filing Doc
4 Period Feb 23, 2026 Filing Doc
4 Period Feb 20, 2026 · 5 forms Filing Doc
4 Period Feb 18, 2026 · 2 forms Filing Doc

Updated 3 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$153.16M -$167.38M -$219.88M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $480.19M $414.67M $386.76M
Total non-current assets * $3.99M $207.16M $61.62M
Total assets $484.18M $621.82M $448.37M
Total current liabilities $28.14M $30.65M $37.74M
Total non-current liabilities * $2.15M $0.849M $1.9M
Total equity $453.7M $590.33M $408.73M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$134.28M -$145.3M -$175.75M
Cash from investing $35.81M -$136.31M $179.99M
Cash from financing $40.75M $266.19M $1.09M
Net change in cash * -$57.72M -$15.43M $5.33M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders